Yardena Samuels

22.1k total citations · 5 hit papers
78 papers, 11.7k citations indexed

About

Yardena Samuels is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yardena Samuels has authored 78 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 40 papers in Oncology and 18 papers in Immunology. Recurrent topics in Yardena Samuels's work include Melanoma and MAPK Pathways (19 papers), Immunotherapy and Immune Responses (15 papers) and PI3K/AKT/mTOR signaling in cancer (14 papers). Yardena Samuels is often cited by papers focused on Melanoma and MAPK Pathways (19 papers), Immunotherapy and Immune Responses (15 papers) and PI3K/AKT/mTOR signaling in cancer (14 papers). Yardena Samuels collaborates with scholars based in United States, Israel and United Kingdom. Yardena Samuels's co-authors include Victor E. Velculescu, Bert Vogelstein, Kenneth W. Kinzler, Steve Szabo, Natalie Silliman, Janine Ptak, Steven A. Rosenberg, Hai Yan, Kajsa Ericson and Alberto Bardelli and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Yardena Samuels

78 papers receiving 11.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Frequency of Mutations of the PIK3CA Gene in Human Cancers

2004 2.7k citations Yardena Samuels, Zhenghe Wang et al. Science profile →
Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

2013 806 citations Paul F. Robbins, Yong‐Chen Lu et al. profile →
Mutant PIK3CA promotes cell growth and invasion of human cancer cells

2005 727 citations Yardena Samuels, Luis A. Díaz et al. Cancer Cell profile →
The PIK3CA gene is mutated with high frequency in human breast cancers

2004 519 citations Yardena Samuels, Natalie Silliman et al. profile →
Mechanisms of immune activation and regulation: lessons from melanoma

2022 149 citations Shelly Kalaora, Yardena Samuels et al. profile →

Peers

Countries citing papers authored by Yardena Samuels

Since Specialization

Citations

This map shows the geographic impact of Yardena Samuels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yardena Samuels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yardena Samuels more than expected).

Fields of papers citing papers by Yardena Samuels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yardena Samuels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yardena Samuels. The network helps show where Yardena Samuels may publish in the future.

Co-authorship network of co-authors of Yardena Samuels

This figure shows the co-authorship network connecting the top 25 collaborators of Yardena Samuels. A scholar is included among the top collaborators of Yardena Samuels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yardena Samuels. Yardena Samuels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Breaking the performance ceiling for neoantigen immunogenicity prediction	Nature Cancer	Hugh O’Brien, Max Salm et al.	5
2	The landscape of T cell antigens for cancer immunotherapy	Nature Cancer	Nadja Salomon, Yochai Wolf et al.	67
3	Large-Scale Immunopeptidome Analysis Reveals Recurrent Posttranslational Splicing of Cancer- and Immune-Associated Genes	Molecular & Cellular Proteomics	Ronen Levy, Wayne Paes et al.	11
4	Intratumor Heterogeneity and Antitumor Immunity Shape One Another Bidirectionally	Clinical Cancer Research	Yochai Wolf, Yardena Samuels	28
5	PhISCS-BnB: a fast branch and bound algorithm for the perfect tumor phylogeny reconstruction problem	Bioinformatics	Farid Rashidi Mehrabadi, Salem Malikić et al.	14
6	MEK Inhibition Reverses Aberrant Signaling in Melanoma Cells through Reorganization of NRas and BRAF in Self Nanoclusters	Cancer Research	Rand Arafeh, Yair Neve-Oz et al.	2
7	Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells	Cancer Research	Or‐Yam Revach, Oded Sandler et al.	34
8	Exome Sequencing of ABCB5 Identifies Recurrent Melanoma Mutations that Result in Increased Proliferative and Invasive Capacities	Journal of Investigative Dermatology	James P. Madigan, Jared J. Gartner et al.	9
9	Cancer Exome-Based Identification of Tumor Neo-Antigens Using Mass Spectrometry	Methods in molecular biology	Shelly Kalaora, Yardena Samuels	5
10	The functional relevance of somatic synonymous mutations in melanoma and other cancers	Pigment Cell & Melanoma Research	Valer Gotea, Jared J. Gartner et al.	41
11	Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions	Clinical Cancer Research	Yong‐Chen Lu, Xin Yao et al.	304
12	Mutational Signatures of De-Differentiation in Functional Non-Coding Regions of Melanoma Genomes	PLoS Genetics	Stephen C.J. Parker, Jared J. Gartner et al.	8
13	Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer	Science	David A. Solomon, Taeyeon Kim et al.	311
14	Mutational and Functional Analysis Reveals ADAMTS18 Metalloproteinase as a Novel Driver in Melanoma	Molecular Cancer Research	Xiaomu Wei, Todd D. Prickett et al.	41
15	Genetic inactivation of AKT1 , AKT2 , and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation	Proceedings of the National Academy of Sciences	Kajsa Ericson, Christine Gan et al.	106
16	Mutational Inactivation of PTPRD in Glioblastoma Multiforme and Malignant Melanoma	Cancer Research	David A. Solomon, Jung-Sik Kim et al.	102
17	The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations	Science	Chuan‐Hsiang Huang, Diana Mandelker et al.	446
18	Oncogenic PI3K and its role in cancer	Current Opinion in Oncology	Yardena Samuels, Kajsa Ericson	415
19	Mutant PIK3CA promotes cell growth and invasion of human cancer cells breakdown →	Cancer Cell	Yardena Samuels, Luis A. Díaz et al.	727
20	High Frequency of Mutations of the PIK3CA Gene in Human Cancers breakdown →	Science	Yardena Samuels, Zhenghe Wang et al.	2708

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact